ISCHEMIA Trial Receives Top Clinical Research Award

The ISCHEMIA Trial, a groundbreaking cardiovascular study coauthored by David Maron, MD, C.F. Rehnborg professor of medicine and Director of Preventive Cardiology, received the Clinical Research Forum’s (CRF) prestigious Herbert Pardes Clinical Research Excellence Award in recognition of its high degree of innovation and impact on human disease.

Maron, who partnered with Judith Hochman, MD, professor and associate director of cardiology at the NYU Grossman School of Medicine, to lead the project, explains that the study was designed to determine whether adding invasive procedures to medical therapies improved outcomes for stable patients with coronary artery disease.

The first of its kind, the clinical trial revealed no difference in the likelihood of an adverse event, including heart attack and death, between those treated with surgery and those with medicine and lifestyle changes. The researchers say the findings underscore the importance of shared decision making between physicians and patients, as well as a decreased need for stinting in bypass surgery.

As noted in a CRF announcement, the research shows “potential to improve the management of millions of patients around the world.”

The ISCHEMIA Trial was also named a CFR 2021 Top 10 Clinical Research Achievement Award Finalist. Maron and Hochman were honored during a virtual presentation on March 30th.